Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Natalia Huerta
In Vitro Activity of Levonadifloxacin (WCK 771) Against Chlamydia Pneumoniae
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
In Vitro Activity of a New Ketolide Antibiotic, HMR 3647, Against Chlamydia Pneumoniae
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Activity of a Novel Diaminopyrimidine Compound, Iclaprim, Against Chlamydia Trachomatis and C. Pneumoniae
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Infection of Human Monocytes by Chlamydia Pneumoniae and Chlamydia Trachomatis: An in Vitro Comparative Study
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
In Vitro and in Vivo Activity of Β-Lactams in Combination With Novel Β-Lactam Enhancers, Zidebactam and WCK 5153, Against Multidrug-Resistant Metallo-Β-Lactamase Producing Klebsiella Pneumoniae
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Lack of in Vitro Activity of Cefoxitin, Cefamandole, Cefuroxime, and Piperacillin Against Chlamydia Trachomatis.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Chlamydia Pneumoniae
Japanese Journal of Pediatric Pulmonology
In Vitro Activity of Tebipenem, a New Oral Carbapenem Antibiotic, Against Penicillin-Nonsusceptible Streptococcus Pneumoniae
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Activity of Carbapenems Alone and in Combination With Amikacin Against KPC-Producing Klebsiella Pneumoniae
Journal of Clinical Medicine Research
In Vitro Synergy of Clindamycin and Aminoglycosides Against Chlamydia Trachomatis.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
